header
Maine Medicine Weekly E-Update, July 20, 2022

In This Issue
MAINE MEDICINE WEEKLY UPDATE
July 20, 2022
LEAD STORIES
Monkeypox Now a Reportable Condition in Maine
Federal COVID-19 Public Health Emergency Extended
Novavax COVID-19 Vaccine Authorized by FDA & CDC
Maine Joins National Launch Of 988 Suicide And Crisis Lifeline
MORE CDC NEWS
Recent Reports of Human Parechovirus (PeV) in the United States
PHYSICIANS IN THE NEWS
Maine Physicians Direct Primacy Care Model to Improve Medical Care
LEGISLATIVE ADVOCACY
MMA Government Affairs Developing 2023-2024 State Legislative Agenda
SUBSTANCE USE DISORDER
CDC Launches New Addiction Medicine Toolkit
Revised Narcotic Treatment Program Manual
Governor Mills Hosts 4th Annual Opioid Response Summit
COVID CORNER
Concerns About BA.5 Variants Contagiousness, Hospitalizations
MMA'S ANNUAL MEETING
Sign Up Now for the MMA 169th Annual Session in Bar Harbor!
CANCER CARE
ASGE Colon Cancer Appropriate Screening Test Campaign
AWARD NOMINATIONS
Nominations Due by July 29 for 2022 Mary Cushman, MD Award
UPCOMING EVENTS
Upcoming Specialty Society Meetings
HEALTHCARE EMPLOYMENT OPPORTUNITIES
Island Physician - MD/DO
Family Medicine Physician - Penobscot Community Health Care’s Brewer Medical Center
Physician
Thoracic Surgeon Opportunity at Progressive Medical Center in Maine
Lead Hematology/Oncology Opportunity in Northern Maine
Experienced Emergency Medicine PA Opportunity in Bangor, Maine!

 
Search Back Issues



 

 

 

 

 

 


Follow Us:
MORE CDC NEWS

Recent Reports of Human Parechovirus (PeV) in the United States

The Centers for Disease Control and Prevention issued a Health Alert Network (HAN) Health Advisory to inform physicians and public health departments that parechovirus (PeV) is currently circulating the Untied States. Since May 2022, the CDC has received reports from healthcare providers in multiple states of PeV infections in neonates and young infants.

Parechoviruses are a group of viruses known to cause a spectrum of disease in humans. Physicians are encouraged to include PeV in the differential diagnoses of infants presenting with fever, sepsis-like syndrome, or neurological illness (seizures, meningitis) without another known cause and to test for PeV in children with signs and symptoms compatible with PeV infection. Commercial laboratory assays, multiplex platforms for meningitis and encephalitis, and testing through state public health laboratories are available to test cerebrospinal fluid (CSF) for PeV to confirm a diagnosis, CDC laboratory support is also available.

CDC Recommendations for Physicians

  • Be aware that PeVs circulate in the summer and fall. In the absence of an identified pathogen, consider PeV infection in a neonate or infant presenting with fever, sepsis-like syndrome, or signs of neurologic involvement.
  • Become familiar with specimen collection, storage, and shipping procedures. Testing for PeV is available at commercial clinical laboratories and SPHLs, and hospitals may use multiplex meningitis and encephalitis panels for CSF testing that include PeV. Testing and typing for PeV are also available at CDC when other options are unavailable; clinicians should still work with their state public health department to send specimens to CDC. Please contact PicornaLab@cdc.gov before submitting specimens. Accepted specimens include CSF, throat or nasopharyngeal swabs, blood, and stool.
  • Consider cohorting an infant hospitalized with detected PeV infection with other affected infant(s) to avoid healthcare-associated transmission in nurseries or neonatal intensive care units.
  • Use Contact, Droplet, and Standard Precautions. In most clinical situations, alcohol-based hand sanitizer (ABHS) is preferred for cleaning hands with an alcohol content of at least 60%. However, soap and water is the preferred method after patient care involving diapering or toileting, before eating or feeding, and if hands are visibly soiled (e.g., dirt, blood, body fluids). Although non-enveloped viruses may be less susceptible to alcohol than enveloped viruses, ABHS offers benefits in skin tolerance, compliance, and overall effectiveness, especially when combined with glove use. See Core Infection Prevention and Control Practices for Safe Healthcare Delivery in All Settings –Recommendations of the HICPAC for more information.
  • Consult the state health department with questions about PeV.

Read More click here

 

< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm


Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©